Annual Dialysis Data Report 2015, JSDT Renal Data Registry
Tóm tắt
The annual survey of Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was conducted for 4380 dialysis facilities at the end of 2015, among which 4321 facilities (98.7%) responded. The response rate of the 2015 survey was comparable with the past, even though it was the first year after the new anonymization method. The number of chronic dialysis patients in Japan continues to increase every year; it has reached 324,986 at the end of 2015. The mean age was 67.86 years. At the end of 2015, the prevalence rate was 2592 patients per million population. Diabetic nephropathy was the most common primary disease among the prevalent dialysis patients (38.4%), followed by chronic glomerulonephritis (29.8%) and nephrosclerosis (9.5%). The rate of diabetic nephropathy and nephrosclerosis has been increasing year by year, whereas that of chronic glomerulonephritis was declining. The number of incident dialysis patients during 2015 was 39,462; it has remained stable since 2008. The average age was 69.20 years, and diabetic nephropathy (43.7%) was the most common cause in the incident dialysis patients. These patients caused by diabetes did not change in number for the last several years. Meanwhile, 31,608 patients died in 2015; the crude mortality rate was 9.6%. The patients treated by hemodiafiltration (HDF) have been increasing rapidly from the revision of medical reimbursement for HDF therapy in 2012. It has attained 53,776 patients at the end of 2015, which were 10,493 greater than that in 2014. In particular, the number of online HDF patients increased about ten times 2012. The number of peritoneal dialysis (PD) patients was 9322 in 2015, which was slightly increased than 2014. Twenty percent of PD patients treated in the combination of hemodialysis (HD) or HDF therapy. Five hundred seventy-two patients underwent home HD therapy at the end of 2015; it increased by 43 from 2014. Further JRDR data analyses could clarify the relationships between various dialysis modalities, patient care, and clinical outcomes; furthermore, it could also make it possible to establish clinical practice guidelines or medical reimbursement revisions based on the evidence. JRDR was approved by the ethical committee of JSDT and has been registered in the “University hospital Medical Information Network (UMIN) Clinical Trials Registry” as an approved number of
UMIN000018641
since 2015.
Tài liệu tham khảo
Nakai S. The history of Japanese Society for Dialysis Therapy Registry. J Jpn Soc Dial Ther. 2010;43:119–52. (in Japanese)
Masakane I. Recent trends of dialysis therapy in Japan. J Jpn Soc Dial Ther. 2016;49:211–8. (in Japanese)
Nakai S, Wakai K, Yamagata K, Iseki K, Tsubakihara Y. Prediction of dialysis patients in Japan: based on Japanese Society for Dialysis Therapy Registry. J Jpn Soc Dial Ther. 2012;45:599–613. (in Japanese)
Japanese society for dialysis therapy: An Overview of Regular Dialysis Treatment in Japan, the CD-ROM Report (as of 31 December 2015). Japanese society for dialysis therapy. Tokyo, 2016.
Ethical Guidelines for Medical and Health Research Involving Human Subjects Ethical Guidelines for Medical and Health Research Involving Human Subjects. Ministry of health, labor and welfare, Tokyo. 2017. http://wwwhourei.mhlw.go.jp/cgi-bin/t_docframe2.cgi?MODE=hourei&DMODE=SEARCH&SMODE=NORMAL&KEYWORD=%97%cf%97%9d%8e%77%90%6a&EFSNO=230&FILE=FIRST&POS=0&HITSU=16. Accessed 24 Sep 2017.
JSDT Renal Data Registry. Japanese Society for Dialysis Therapy, Tokyo. 2017. http://www.jsdt.or.jp/Overview_2.html. Accessed 24 Sep 2017.
Statistic Bureau, Home Page/ Population Sencus, Ministry of Internal Affaris nad Communications. http://www.stat.go.jp/english/data/kokusei/index.htm. Accessed 14 Jan 2018.
Chapter 13: International Comparison, the 2015 USRDS Annual Data Report. United States Renal Data System, Washington. 2016 Accessed 24 Sept 2017.
Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, Kimata N, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2010). Ther Apher Dial. 2012;16:483–521.
Kawanishi H, Akiba T, Masakane I, Tomo T, Mineshima M, Kawasaki T, et al. Standard on microbiological management of fluids for hemodialysis and related therapies by the Japanese Society for Dialysis Therapy 2008. Ther Apher Dial. 2009;13:161–6.
Hasegawa T, Nakai S, Masakane I, Watanabe Y, Iseki K, Tsubakihara Y. Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study. Am J Kidney Dis. 2015;65:889–904.
Masakane I, Kawanishi H, Mineshima M, Takemoto Y, Uchono J, Hoshino T, et al. 2011 JSDT standard on the management of endotoxin retentive filter for dialysis and related therapies. Ther Apher Dial. 2013;17:229–40.